These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 23026574

  • 1. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 2. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Einstein (Sao Paulo); 2012 Oct; 10(3):278-85. PubMed ID: 23386004
    [Abstract] [Full Text] [Related]

  • 3. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 6. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013 Jul; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 7. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Jul; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

  • 8. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 9. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 10. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 11. [Predictors of mortality among liver transplant candidates].
    Erez D, Ben Ari Z, Michowitz R, Mor E.
    Harefuah; 2011 Jan; 150(1):16-20, 70, 69. PubMed ID: 21449150
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil.
    Basto ST, Villela-Nogueira CA, Tura BR, Coelho HS, Ribeiro J, Fernandes ES, Schmal AF, Victor L, Luiz RR, Perez RM.
    Liver Transpl; 2011 Sep; 17(9):1013-20. PubMed ID: 21604358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [Abstract] [Full Text] [Related]

  • 17. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 18. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.